1166 related articles for article (PubMed ID: 15011835)
41. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
[TBL] [Abstract][Full Text] [Related]
42. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
44. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
45. Significance of long-term follow-up of early gastric cancer.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 Mar; 13(3):363-9. PubMed ID: 16485155
[TBL] [Abstract][Full Text] [Related]
46. [Rational evaluation of different lymph node dissection].
Chen JQ; Wang SB; Qi CL
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
[TBL] [Abstract][Full Text] [Related]
47. Surgical therapy of gastric stump carcinoma--a retrospective analysis of 109 patients.
Piso P; Meyer HJ; Edris C; Jähne J
Hepatogastroenterology; 1999; 46(28):2643-7. PubMed ID: 10522057
[TBL] [Abstract][Full Text] [Related]
48. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
49. [Clinicopathological characteristics and prognosis of remnant stomach cancer--report of 45 cases].
Xu DK; Zhao P; Wang CF; Shao YF; Lin HW; Tian YT
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):852-4. PubMed ID: 17416009
[TBL] [Abstract][Full Text] [Related]
50. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
51. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer.
Tokunaga M; Hiki N; Fukunaga T; Ohyama S; Yamada K; Yamaguchi T
Ann Surg Oncol; 2009 Jun; 16(6):1514-9. PubMed ID: 19290492
[TBL] [Abstract][Full Text] [Related]
52. Results of D2 gastrectomy for gastric adenocarcinoma: 10-year experience in Thai patients.
Euanorasetr C; Lertsithichai P
J Med Assoc Thai; 2007 Feb; 90(2):291-300. PubMed ID: 17375634
[TBL] [Abstract][Full Text] [Related]
53. Gastric stump carcinoma after partial gastrectomy for benign gastric lesion: what is feasible as standard surgical treatment?
Kodera Y; Yamamura Y; Torii A; Uesaka K; Hirai T; Yasui K; Morimoto T; Kato T; Kito T
J Surg Oncol; 1996 Oct; 63(2):119-24. PubMed ID: 8888805
[TBL] [Abstract][Full Text] [Related]
54. Surgical treatment for advanced carcinoma of the gastric remnant.
Isozaki H; Tanaka N; Fujii K; Nomura E; Tanigawa N
Hepatogastroenterology; 1998; 45(23):1896-900. PubMed ID: 9840172
[TBL] [Abstract][Full Text] [Related]
55. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
56. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
57. [Stage-adapted radical principles in gastric carcinoma].
Verreet PR
Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
[TBL] [Abstract][Full Text] [Related]
59. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
60. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
